Company: SMNR
Filing Date: 2025-08-13
Form Type: 424B3
Source: 0001193125-25-179226
Chunk: 609

Company: Semnur Pharmaceuticals, Inc.
Filing Date: 2025-08-13
Form: 424B3
Chunk 609
---
 conduct and ethics will be posted on its website at www.semnurpharma.com. Information contained on or accessible through such website is not a part of this proxy statement/prospectus, and the inclusion of the website address in this proxy statement/prospectus is an inactive textual reference only. New Semnur intends to disclose any amendments to its code of business conduct and ethics, or any waivers of its requirements, on its website to the extent required by the applicable rules and exchange requirements. Compensation Committee Interlocks and Insider Participation None of the intended members of New Semnur’s compensation committee is currently, or has been at any time in the past year, one of Semnur’s officers or employees. Other than Dr. Ji and Mr. Shah, none of New Semnur’s expected executive officers currently serves, or has served during the last year, as a member of the board of directors or compensation committee of any entity that has one or more executive officers serving as a member of the New Semnur Board or compensation committee. Please see the section of this proxy statement/prospectus titled “ Semnur’s Executive Compensation” for information regarding the compensation of Dr. Ji and Mr. Shah. Limitation of Liability and Indemnification of Directors and Officers The Proposed Charter and the Proposed Bylaws, which will become effective immediately prior to the consummation of the Business Combination, will contain provisions that limit the liability of New Semnur’s directors for monetary damages to the fullest extent permitted by the DGCL. Consequently, New Semnur’s directors will not be personally liable to New Semnur or its stockholders for monetary damages for any breach of fiduciary duties as directors, except liability for the following:

| • |     | any breach of their duty of loyalty to New Semnur or its stockholders; |

| • |     | acts or omissions not in good faith or that involve intentional misconduct or a knowing violation of law; |

| • |     | unlawful payments of dividends or unlawful stock repurchases or redemptions in violation of the DGCL; |

| • |     | any transaction from which the director derived an improper personal benefit; or |

| • |     | with respect to any officer, any action by or in the right of the corporation. |

The Proposed Charter will also provide that if the DGCL is amended to permit further elimination or limitation of the personal liability of directors or officers, then the liability of New Semnur’s directors or officers will be eliminated or